Rohto Pharmaceutical ,Ltd. Current Cash

Rohto Pharmaceutical ,Ltd. (RPHCF) currently reports a current cash of $84B as of June 2026. That compares with $76B in the prior-year period — up 10.4% year over year. Use the charts on this page to explore Rohto Pharmaceutical ,Ltd.'s current cash history and peer comparisons.

Rohto Pharmaceutical ,Ltd.'s current cash increased from $76B to $84B — a 10.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Rohto Pharmaceutical ,Ltd. reported $84B in current cash as of June 2026. That compares with $76B in the prior-year period — up 10.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $84B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Rohto Pharmaceutical ,Ltd., and consider following RPHCF for alerts when major investors trade the stock.